Kevin Daniels - 31 Dec 2021 Form 4 Insider Report for CORE LABORATORIES N V (CLB)

Role: CAO & Treasurer
Signature: /s/ Mark Tattoli, Attorney-in-Fact
Issuer symbol: CLB
Transactions as of: 31 Dec 2021
Transactions value $: -$33,376
Form type: 4
Filing time: 04 Jan 2022, 16:52:47 UTC
Previous filing: 03 Dec 2021
Next filing: 17 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CLB	Common Shares	Tax liability	-$33.4K	-1.5K	-23.49%	$22.31^*	4.87K	31 Dec 2021	Direct
transaction	CLB	Common Shares	Options Exercise	$0	+3.8K	+147.86%	$0.00	6.37K	31 Dec 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CLB	Performance Shares	Options Exercise	$0	-3.8K	-100%	$0.00^*	0	31 Dec 2021	Common Shares	3.8K	$0.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These awards vested at the end of a three-year performance period that began on January 1, 2019 and ended December 31, 2021 (the "Performance Period"). The restricted performance shares would vest only upon the Company's return on invested capital being in the top 75th percentile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period.

Content

These awards vested at the end of a three-year performance period that began on January 1, 2019 and ended December 31, 2021 (the "Performance Period"). The restricted performance shares would vest only upon the Company's return on invested capital being in the top 75th percentile of the Company's peers as published by Bloomberg upon the close of the NYSE market on the last day of the Performance Period.